Shandong Weigao Group Medical Polymer Co (UK2) Stock Price & Analysis
UK2 Stock Chart & Stats
- Day’s Range
- EUR 0.34 - EUR 0.34
- 52-Week Range
- EUR 0.32 - EUR 0.65
- Previous Close
- EUR 0.34
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- EUR 1.62B
- Enterprise Value
- EUR 11.73B
- Total Cash (Recent Filing)
- EUR 8.92B
- Total Debt (Recent Filing)
- EUR 4.96B
- Price to Earnings (P/E)
- 9.1
- Beta
- 0.24
- Next Earnings
- Mar 30, 2027 (Est.)
- EPS Estimate
- 0.02
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 5.12%
Bulls Say, Bears Say
Bulls Say
Recurring Consumables Demand
The business model is supported by recurring clinical consumption rather than infrequent discretionary purchases. Daily use of infusion, blood-related, and other disposable products can create repeat hospital orders, providing a durable demand base as healthcare utilization and procurement coverage develop.
Conservative Leverage
Conservative leverage gives the company financial flexibility while operating performance is under pressure. Manageable debt reduces balance-sheet risk, limits the burden of interest and refinancing, and leaves greater capacity to maintain operations or fund product and manufacturing priorities.
Positive Cash Generation
The company continues to generate positive operating and free cash flow, showing that its profitable consumables operations convert into funding for the business. This supports ongoing investment and financial resilience, even though recent cash-flow growth has weakened compared with prior periods.
Bears Say
Sharp Revenue Decline
The sharp 2025 revenue contraction indicates a meaningful loss of operating momentum after earlier stagnation. If sustained, weaker sales would reduce scale benefits, limit investment capacity, and make it harder for the company to expand hospital coverage or offset competitive and procurement pressure.
Long-term Margin Compression
Multi-year gross and net margin erosion shows that profitability has become less efficient over time. Continued pressure could reduce earnings resilience and constrain reinvestment, while also indicating that product mix, pricing, or operating economics are not preserving historical returns.
Weaker Cash-flow Momentum
The decline in free cash flow reduces the pace at which the company can internally finance growth, shareholder returns, or balance-sheet strengthening. Although cash generation remains positive, weaker recent conversion makes the business more dependent on restoring sales and profitability momentum.
Shandong Weigao Group Medical Polymer Co News
UK2 FAQ
What was Shandong Weigao Group Medical Polymer Co’s price range in the past 12 months?
What is Shandong Weigao Group Medical Polymer Co’s market cap?
When is Shandong Weigao Group Medical Polymer Co’s upcoming earnings report date?
How were Shandong Weigao Group Medical Polymer Co’s earnings last quarter?
Is Shandong Weigao Group Medical Polymer Co overvalued?
Does Shandong Weigao Group Medical Polymer Co pay dividends?
What is Shandong Weigao Group Medical Polymer Co’s EPS estimate?
How many shares outstanding does Shandong Weigao Group Medical Polymer Co have?
What happened to Shandong Weigao Group Medical Polymer Co’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Shandong Weigao Group Medical Polymer Co?
What is the TipRanks Smart Score and how is it calculated?
Shandong Weigao Group Medical Polymer Co Stock Smart Score
Company Description
Shandong Weigao Group Medical Polymer Co
Shandong Weigao Group Medical Polymer Company Limited, founded in 2000 and situated in Weihai, People's Republic of China, specializes in the research, development, production, and distribution of disposable medical devices across mainland China. The company structures its extensive operations into several core divisions, including Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and other specialized segments. Its comprehensive product range covers a vast array of essential healthcare items. This includes devices for both vascular and non-vascular access, such as infusion sets, syringes, and specialized puncture needles, alongside various clinical collection kits. Shandong Weigao also provides solutions for wound care, offering sutures, healing dressings, cleaning products, and support devices for non-vascular catheters. In the realm of blood management, it supplies equipment for collection, storage, separation, and sterilization. The company is also a manufacturer of prefilled and pre-flush syringes, as well as instruments for blood collection and glucose monitoring. Its portfolio further extends to anesthesia consumables (general, local, and auxiliary), intensive care unit (ICU) equipment, and tools for both open and minimally invasive surgical procedures. Beyond disposables, the firm is a key producer of orthopedic devices, instruments for tumor and blood vessel interventions, and advanced medical components such as implantation materials and artificial organs. It also ventures into industrial manufacturing, producing medical-grade PVC granules, various plastic packaging materials, carton boxes, automated industrial equipment and parts, molds, and hemodialysis machines, encompassing Type I, Type II, and Type III medical devices. In addition to its manufacturing activities, Shandong Weigao offers a range of supporting services. These include finance leasing and factoring, wholesale distribution of Type I, surgical, and other disposable medical products. The company also provides asset management, enterprise consulting, management advisory, and comprehensive logistics and storage solutions, while actively exporting its products to international markets. Operating under recognized brands like Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing, the company serves a diverse clientele that includes hospitals, blood banks, various other medical facilities, and a broad network of distributors.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Rinan Cong
- Employees
- 13,310
- Website
- www.weigaogroup.com
- Address
- 1 Weigao Road, Weihai, SD, 264210, CN
Shandong Weigao Group Medical Polymer Co (UK2) Earnings & Revenues
UK2 Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 7 | 4 | 11 |
| Technical Analysis | 4 | 4 | 2 |
| Moving Averages | 3 | 0 | 9 |
